81 FR 10666 - Agency Information Collection Activities; Submission for OMB Review; Comment Request; Pharmacy Billing Requirements

DEPARTMENT OF LABOR
Office of the Secretary

Federal Register Volume 81, Issue 40 (March 1, 2016)

The Department of Labor (DOL) is submitting the Office of Workers' Compensation Programs (OWCP) sponsored information collection request (ICR) titled, ``Pharmacy Billing Requirements,'' to the Office of Management and Budget (OMB) for review and approval for continued use, without change, in accordance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501 et seq.). Public comments on the ICR are invited.

[Federal Register Volume 81, Number 40 (Tuesday, March 1, 2016)]
[Notices]
[Pages 10666-10667]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-04397]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Office of the Secretary


Agency Information Collection Activities; Submission for OMB 
Review; Comment Request; Pharmacy Billing Requirements

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Labor (DOL) is submitting the Office of 
Workers' Compensation Programs (OWCP) sponsored information collection 
request (ICR) titled, ``Pharmacy Billing Requirements,'' to the Office 
of Management and Budget (OMB) for review and approval for continued 
use, without change, in accordance with the Paperwork Reduction Act 
(PRA) of 1995 (44 U.S.C. 3501 et seq.). Public comments on the ICR are 
invited.

DATES: The OMB will consider all written comments that agency receives 
on or before March 31, 2016.

ADDRESSES: A copy of this ICR with applicable supporting documentation; 
including a description of the likely respondents, proposed frequency 
of response, and estimated total burden may be obtained free of charge 
from the RegInfo.gov Web site at http://www.reginfo.gov/public/do/PRAViewICR?ref_nbr=201601-1240-010 or by contacting Michel Smyth by 
telephone at 202-693-4129, TTY 202-693-8064, (these are not toll-free 
numbers) or sending an email to [email protected].
    Submit comments about this request by mail or courier to the Office 
of Information and Regulatory Affairs, Attn: OMB Desk Officer for DOL-
OWCP, Office of Management and Budget, Room 10235, 725 17th Street NW., 
Washington, DC 20503; by Fax: 202-395-5806 (this is not a toll-free 
number); or by email: [email protected]. Commenters are 
encouraged, but not required, to send a courtesy copy of any comments 
by mail or courier to the U.S. Department of Labor-OASAM, Office of the 
Chief Information Officer, Attn: Departmental Information Compliance 
Management Program, Room N1301, 200 Constitution Avenue NW., 
Washington, DC 20210; or by email: [email protected].

FOR FURTHER INFORMATION CONTACT: Michel Smyth by telephone at 202-693-
4129, TTY 202-693-8064, (these are not toll-free numbers) or sending an 
email to [email protected].

SUPPLEMENTARY INFORMATION: This ICR seeks to extend PRA authorization 
for the Pharmacy Billing Requirements information collection. The OWCP 
is the agency responsible for administration of the Federal Employees' 
Compensation Act (FECA), 5 U.S.C. 8101 et seq.; the Black Lung Benefits 
Act (BLBA), 30 U.S.C. 901 et seq.; and the Energy Employees 
Occupational Illness Compensation Program Act of 2000 (EEOICPA), 42 
U.S.C. 7384 et seq. All three of these statutes require the OWCP to pay 
for covered medical treatment provided to beneficiaries; this medical 
treatment can include medicinal drugs dispensed by pharmacies. In order 
to determine whether amounts billed for drugs are appropriate, the OWCP 
must receive the required data elements--including the name of the 
patient/beneficiary, the National Drug Code number of each drug 
prescribed, the quantity provided, the prescription number, and the 
date the prescription was filled. The regulations implementing these 
statutes require the collection of information needed to enable the 
OWCP to determine whether bills for drugs submitted directly by 
pharmacies or as reimbursement requests submitted by claimants should 
be paid. See 20 CFR 10.801, 30.701, 725.701, and 725.705. FECA section 
9, BLBA section 413, and EEOICPA section 3629(c) authorize this 
information collection. See 5 U.S.C. 8103, 30 U.S.C. 936, and 42 U.S.C. 
7384t.
    This information collection is subject to the PRA. A Federal agency 
generally cannot conduct or sponsor a collection of information, and 
the public is generally not required to respond to an information 
collection, unless it is approved by the OMB under the PRA and displays 
a currently valid OMB Control Number. In addition, notwithstanding any 
other provisions of law, no person shall generally be subject to 
penalty for failing to comply with a collection of information that 
does not display a valid Control Number. See 5 CFR 1320.5(a) and 
1320.6. The DOL obtains OMB approval for this information collection 
under Control Number 1240-0050.
    OMB authorization for an ICR cannot be for more than three (3) 
years without renewal, and the DOL seeks to extend PRA authorization 
for this information collection for three (3) more years, without any 
change to existing requirements. The DOL notes that existing 
information collection requirements submitted to the OMB receive a 
month-to-month extension while they undergo review. For additional 
substantive information about this ICR, see the related notice 
published in the Federal Register on August 19, 2015 (80 FR 50327).
    Interested parties are encouraged to send comments to the OMB, 
Office of Information and Regulatory Affairs at the address shown in 
the ADDRESSES section within thirty (30) days of publication of this 
notice in the Federal Register. In order to help ensure appropriate 
consideration, comments should mention OMB Control Number 1240-0050. 
The OMB is particularly interested in comments that:
     Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
     Evaluate the accuracy of the agency's estimate of the 
burden of the proposed collection of information, including the 
validity of the methodology and assumptions used;
     Enhance the quality, utility, and clarity of the 
information to be collected; and
     Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses.
    Agency: DOL-OWCP.
    Title of Collection: Pharmacy Billing Requirements.
    OMB Control Number: 1240-0050.
    Affected Public: Private Sector--businesses or other for-profits 
and not-for-profit institutions.
    Total Estimated Number of Respondents: 4,344.
    Total Estimated Number of Responses: 1,453,300.
    Total Estimated Annual Time Burden: 24,421 hours.
    Total Estimated Annual Other Costs Burden: $0.

    Authority:  44 U.S.C. 3507(a)(1)(D).


[[Page 10667]]


     Dated: February 22, 2016.
Michel Smyth,
Departmental Clearance Officer.
[FR Doc. 2016-04397 Filed 2-29-16; 8:45 am]
 BILLING CODE 4510-CR-P